Wellington Partners leads €14m financing round for UroMems

The financing round included a €12m series-A led by Wellington and joined by BPI France via its €340m vehicle Fonds Accélération Biotechnologies Santé, and by Cita Investissement, CEA Investissement and Partners AG.

The series-A was completed by an extra €2m funding from the Worldwide Innovation Challenge programme, part of BPI's Programme of Investments for the Future.

This financing will enable the group to complete the development of its articial urinary sphincter system and fund its market launch.

Previous funding
Largely privately funded until now, UroMems did receive prior support from incubator BizMedTech, based in Grenoble and accelerating the development of medtech companies internationally. The group was also awarded innovation grants from BPI France and the Worldwide Innovation Challenge prize.

Company
Founded in 2011, UroMems specialises in the design, development and marketing of implantable medical devices for the treatment of severe stress urinary incontinence. The company's headquarters are located on the Minatec campus in Grenoble, a European micro- and nanotechnology innovation hub.

People
Wellington Partners – Rainer Strohnmenger (general partner).
UroMems – Hamid Lamraoui (co-founder/CEO); Pierre Mozer (co-founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• France
• Venture
• BPI France
• Wellington Partners